Department of Environmental Health Sciences, University Medical Centre Freiburg, Freiburg, Germany.
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Mar 15;889-890:24-38. doi: 10.1016/j.jchromb.2012.01.022. Epub 2012 Jan 30.
The search for environmental transformation products of organic pollutants (like drugs) is a difficult task and usually only few compounds are detected. This might be due to effective degradation but could also be a result of analytical deficits dealing with complex matrices. Especially transformation products of very low concentrations in sludge were difficult to identify so far. Additionally, the use of standard separation techniques might lead to the loss of isomeric compounds, which possess identical spectroscopic and spectrometric properties. To date no complete study investigating the environmental fate of any tricyclic antipsychotic drug has been reported. Therefore, this study investigated the popular neuroleptic drug chlorpromazine and its potential transformation by all main environmental pathways: aerobic and anaerobic biodegradation as well as abiotic photolytic degradation by sunlight. Analysis of test samples by high performance liquid chromatography coupled to multiple stage mass-spectrometry (HPLC-MS(n)) allowed the detection of numerous compounds. Further, the use of a special software allowed distinguishing between transformation products of small intensities and background "noise" caused by sludge or matrix. Three aerobic tests of different bacterial density (the Closed Bottle test, OECD 301D; the Manometric Respiratory test, OECD 301F; the modified Zahn-Wellens test, 302B; one anaerobic test (a modified anaerobic degradation test according to ISO 11734) as well as a photodegradation test were performed in the present study. According to the individual test guidelines, chlorpromazine had to be classified as not biodegradable in all of the biodegradation tests. However, a special chromatographic column and gradient along with mass spectrometric fragmentation experiments of higher order uncovered the presence of a total of 61 abiotic and biotic transformation products which where formed during the course of the tests. The structures of three aerobic and one anaerobic biotransformation products were elucidated by HPLC-UV-Flourescence-MS(n). Photodegradation showed almost complete elimination of chlorpromazine after 4h of irradiation with a xenon arc lamp. 57 photoproducts were found and for 28 of them LC-MS(n) fragmentation experiments (n=4) were performed. The molecular structures of the three main photolysis products were elucidated. The identified transformation products are expected to be found in the aquatic environment, yet nothing is known about their ecotoxicological properties. As some of the performed tests showed toxic effects of chlorpromazine or its transformation products on bacteria, further risk assessment upon this drug and its fate is strongly recommended.
寻找有机污染物(如药物)的环境转化产物是一项艰巨的任务,通常只能检测到少数几种化合物。这可能是由于有效降解,但也可能是由于处理复杂基质的分析缺陷造成的。特别是在污泥中浓度非常低的转化产物到目前为止还难以识别。此外,使用标准分离技术可能会导致具有相同光谱和光谱特性的同系物化合物的损失。迄今为止,还没有报道任何三环抗精神病药物的完整环境归宿研究。因此,本研究调查了流行的神经安定药氯丙嗪及其通过所有主要环境途径(好氧和厌氧生物降解以及阳光的非生物光降解)的潜在转化。通过高效液相色谱-多级质谱联用(HPLC-MS(n))对测试样品进行分析,检测到了许多化合物。此外,使用特殊软件,可以区分强度较小的转化产物和由污泥或基质引起的背景“噪声”。本研究进行了三种不同细菌密度的好氧试验(封闭瓶试验,OECD 301D;呼吸计量试验,OECD 301F;改良 Zahn-Wellens 试验,302B;一种厌氧试验(根据 ISO 11734 进行的改良厌氧降解试验)和光降解试验。根据个别试验指南,氯丙嗪在所有生物降解试验中均被归类为不可生物降解。然而,特殊的色谱柱和梯度以及更高阶的质谱碎裂实验揭示了在试验过程中总共形成了 61 种非生物和生物转化产物。通过 HPLC-UV-荧光-MS(n)对三种好氧和一种厌氧生物转化产物的结构进行了阐明。在氙弧灯下照射 4 小时后,光降解几乎完全消除了氯丙嗪。发现了 57 种光产物,并对其中 28 种进行了 LC-MS(n) 碎裂实验(n=4)。阐明了三种主要光解产物的分子结构。预计在水生环境中会发现所识别的转化产物,但它们的生态毒理学性质尚不清楚。由于一些试验显示氯丙嗪或其转化产物对细菌有毒性作用,因此强烈建议对此药物及其归宿进行进一步的风险评估。